Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site

Brain Research

Volumn 1279, Issue , 2009, Pages 21-28

  Kimura, Atsuko ^a   Tyacke, Robin J ^a   Robinson, James J ^b   Husbands, Stephen M ^b   Minchin, Michael C W ^c   Nutt, David J ^a   Hudson, Alan L ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b University of Bath   (United Kingdom)

^c ASTELLAS PHARMA EUROPE LTD   (United Kingdom)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

2 BFI; Creatine kinase; Harmane and psychiatric disorders; Imidazoline binding protein

Indexed keywords

BINDING PROTEIN; CREATINE KINASE; IMIDAZOLINE I2 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MOLECULAR MODEL; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RABBIT; RAT;

ANIMALS; BENZOFURANS; BINDING SITES; BRAIN; CELL MEMBRANE; CHICKENS; CREATINE KINASE, BB FORM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; IMIDAZOLES; IMIDAZOLINE RECEPTORS; MALE; MODELS, MOLECULAR; RABBITS; RATS; RATS, WISTAR;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 67649400330     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.04.044     Document Type: Article

References (46)

1. Alemany R., Olmos G., and García-Sevilla J.A. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 39-47
2. Blum H., Balschi J.A., and Johnson Jr. R.G. Coupled in vivo activity of creatine phosphokinase and the membrane-bound (Na+,K+)-ATPase in the resting and stimulated electric organ of the electric fish Narcine brasiliensis. J. Biol. Chem. 266 (1991) 10254-10259
3. Bousquet P., Feldman J., and Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230 (1984) 232-236
4. Burbaeva G., Savushkina O.K., and Boksha I.S. Creatine kinase BB in brain in schizophrenia. World J. Biol. Psychiatry 4 (2003) 177-183
5. Chan S.L., Brown C.A., Scarpello K.E., and Morgan N.G. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites. Br. J. Pharmacol. 112 (1994) 1065-1070
6. Crawford R.M., Ranki H.J., Botting C.H., Budas G.R., and Jovanovic A. Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo. FASEB J. 16 (2002) 102-104
7. David S., Shoemaker M., and Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Mol. Brain Res. 54 (1998) 276-287
8. Dunant Y., Loctin F., Marsal J., Muller D., Parducz A., and Rabasseda X. Energy metabolism and quantal acetylcholine release: effects of botulinum toxin, 1-fluoro-2,4-dinitrobenzene, and diamide in the Torpedo electric organ. J. Neurochem. 50 (1988) 431-439
9. Dunbar B., and Wilson S.B. A buffer exchange procedure giving enhanced resolution to polyacrylamide gels prerun for protein sequencing. Anal. Biochem. 216 (1994) 227-228
10. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., and Dillon M.P. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol. Sci. 19 (1998) 381-390
11. Escribá P.V., Ozaita A., Miralles A., Reis D.J., and García-Sevilla J.A. Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Brain Res. Mol. Brain Res. 32 (1995) 187-196
12. Escribá P.V., Ozaita A., and Garcia-Sevilla J.A. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Ann. N. Y. Acad. Sci. 881 (1999) 8-25
13. Finn D.P., Marti O., Harbuz M.S., Valles A., Belda X., Marquez C., Jessop D.S., Lalies M.D., Armario A., Nutt D.J., and Hudson A.L. Behavioral, neuroendocrine and neurochemical effects of the imidazoline I(2) receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test. Psychopharmacology (Berl.) 167 (2003) 195-202
14. Florini J.R. Assay of creatine kinase in microtiter plates using thio-NAD to allow monitoring at 405 nM. Anal. Biochem. 182 (1989) 399-404
15. Furter R., Furter-Graves E.M., and Wallimann T. Creatine kinase: the reactive cysteine is required for synergism but is nonessential for catalysis. Biochemistry 32 (1993) 7022-7029
16. García-Sevilla J.A., Escribá P.V., Sastre M., Walzer C., Busquets X., Jaquet G., Reis D.J., and Guimon J. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53 (1996) 803-810
17. García-Sevilla J.A., Escribá P.V., Walzer C., Bouras C., and Guimon J. Imidazoline receptor proteins in brains of patients with Alzheimer's disease. Neurosci. Lett. 247 (1998) 95-98
18. Gines S., Seong I.S., Fossale E., Ivanova E., Trettel F., Gusella J.F., Wheeler V.C., Persichetti F., and MacDonald M.E. Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum. Mol. Genet. 12 (2003) 497-508
19. Heemskerk F.M., Dontenwill M., Greney H., Vonthron C., and Bousquet P. Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem. J. Neurochem. 71 (1998) 2193-2202
20. Hudson A.L., Nutt D.J., Barton C.L., and Hutson P.H. 72 hour morphine treatment decreases the density of Imidazoline-2 sites in rat brain. J. Psychopharmacol. 10 73 (1996) A19
21. Hudson A.L., Nutt D.J., and Husbands S.M. Imidazoline receptors and their role in depression. Pharm. News 8 (2001) 26-32
22. Ikeda K., and Tomonaga M. Creatine kinase immunoreactivity: localization in nerve terminals in the hypothalamic area and superior colliculus of the mouse brain. Neurosci. Lett. 85 (1988) 51-55
23. Jones T.Z., Giurato L., Guccione S., and Ramsay R.R. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. FEBS J. 274 (2007) 1567-1575
24. Krippeit-Drews P., Backer M., Dufer M., and Drews G. Phosphocreatine as a determinant of KATP channel activity in pancreatic beta-cells. Pflugers Arch. Eur. J. Physiol. 445 (2003) 556-562
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Lerner M.H., and Friedhoff A.J. Characterization of a brain particulate bound form of creatine kinase. Life Sci. 26 (1980) 1969-1976
27. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
28. Lione L.A., Nutt D.J., and Hudson A.L. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur. J. Pharmacol. 304 (1996) 221-229
29. Lione L.A., Nutt D.J., and Hudson A.L. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. Eur. J. Pharmacol. 353 (1998) 123-135
30. Matthews R.T., Yang L., Jenkins B.G., Ferrante R.J., Rosen B.R., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18 (1998) 156-163
31. Miki T., Liss B., Minami K., Shiuchi T., Saraya A., Kashima Y., Horiuchi M., Ashcroft F., Minokoshi Y., Roeper J., and Seino S. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat. Neurosci. 4 (2001) 507-512
32. Molderings G.J., Bonisch H., Bruss M., Wolf C., von Kugelgen I., and Gothert M. S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands. Neurochem. Int. 51 (2007) 476-485
33. Morgan N.G., Chan S.L., Mourtada M., Monks L.K., and Ramsden C.A. Imidazolines and pancreatic hormone secretion. Ann. N. Y. Acad. Sci. 881 (1999) 217-228
34. Nutt D.J., French N., Handley S., Hudson A., Husbands S., Jackson H., Jordan S., Lalies M.D., Lewis J., Lione L., et al. Functional studies of specific imidazoline-2 receptor ligands. Ann. N. Y. Acad. Sci. 763 (1995) 125-139
35. Nutt D.J., Lalies M.D., Lione L.A., and Hudson A.L. Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol. 11 (1997) 163-168
36. Ozaita A., Olmos G., Boronat M.A., Lizcano J.M., Unzeta M., and García-Sevilla J.A. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br. J. Pharmacol. 121 (1997) 901-912
37. Parini A., Moudanos C.G., Pizzinat N., and Lanier S.M. The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17 (1996) 13-16
38. Reynolds G.P., Boulton R.M., Pearson S.J., Hudson A.L., and Nutt D.J. Imidazoline binding sites in Huntington's and Parkinson's disease putamen. Eur. J. Pharmacol. 301 (1996) R19-R21
39. Sastre M., Ventayol P., and García-Sevilla J.A. Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts. NeuroReport 7 (1996) 509-512
40. Shainberg A., Yagil G., and Yaffe D. Alterations of enzymatic activities during muscle differentiation in vitro. Dev. Biol. 25 (1971) 1-29
41. Sistermans E.A., De Kok Y.J.M., Peters W., Ginsel L.A., Jap P.H.K., and Wieringa B. Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry. Cell Tissue Res. 280 (1995) 435-446
42. Smith K.L., Jessop D.S., and Finn D.P. Modulation of stress by imidazoline binding sites: implications for psychiatric disorders. Stress. 12 (2009) 97-114
43. Tyacke R.J., Robinson E.S., Nutt D.J., and Hudson A.L. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain. Neuropharmacology 43 (2002) 75-83
44. Wallimann T., and Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133-134 (1994) 193-220
45. Wang H., Regunathan S., Meeley M.P., and Reis D.J. Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol. Pharmacol. 42 (1992) 792-801
46. Wu C.H., Huang H., Arminski L., Castro-Alvear J., Chen Y., Hu Z.Z., Ledley R.S., Lewis K.C., Mewes H.W., Orcutt B.C., Suzek B.E., Tsugita A., Vinayaka C.R., Yeh L.S., Zhang J., and Barker W.C. The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res. 30 (2002) 35-37